Home/Filings/4/0001638599-20-000656
4//SEC Filing

Ianchulev Tsontcho 4

Accession 0001638599-20-000656

CIK 0001682639other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 6:09 PM ET

Size

17.6 KB

Accession

0001638599-20-000656

Insider Transaction Report

Form 4
Period: 2020-06-30
Transactions
  • Award

    Stock Option (right to buy)

    2020-06-30+285,255285,255 total
    Exercise: $2.72Exp: 2030-06-02Common Stock (285,255 underlying)
Holdings
  • Common Stock, par value $.0001

    (indirect: By LLC)
    453,333
  • Class A Warrant

    Exercise: $2.27From: 2020-03-24Exp: 2021-03-24Common Stock (41,216 underlying)
    41,216
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (267,370 underlying)
    267,370
  • Stock Option (right to buy)

    Exercise: $6.20Exp: 2028-07-24Common Stock (124,210 underlying)
    124,210
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Class B Warrant

    Exercise: $2.72From: 2020-03-24Exp: 2025-03-24Common Stock (61,823 underlying)
    61,823
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
  • Stock Option (right to buy)

    Exercise: $3.11Exp: 2029-08-16Common Stock (183,703 underlying)
    183,703
  • Common Stock, par value $.0001

    508,679
  • Common Stock, par value $.0001

    (indirect: By Trust)
    6,000
Footnotes (7)
  • [F1]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F2]This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  • [F3]The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
  • [F4]The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
  • [F5]The option became exercisable as to 11,140 shares on August 7, 2017 and becomes exercisable in equal 11,140 share amounts on each of the 35 one-month anniversaries thereafter.
  • [F6]This option is fully vested.
  • [F7]One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001728916

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:09 PM ET
Size
17.6 KB